Free tool
Healthcare stocks
We cover 281 companies in the Healthcare sector. The median market value in the group is $4.11B. Across the group, the median move over the past trading day is +0.67%. 78% of the 272 with a 200-day average trade above it. Price change over the past year runs from −21.2% to +212.1% across the middle 80 percent of the group, with a median of +28.5%. Across the group, 3 companies currently carry a tier A volume signal.
Other lists in this group
Table
281 of 2,199 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | 1,063.40 EUR | −0.47% | +17.71% | +68.40% |
| LLY | Eli Lilly and Company | $1,233.66 | +3.02% | +14.58% | +78.28% |
| LILY34.SA | Eli Lilly and Company | 211.20 BRL | +3.30% | +9.59% | +69.06% |
| JNJ.DE | Johnson & Johnson | 231.70 EUR | −2.53% | +32.60% | +54.31% |
| JNJ | Johnson & Johnson | $273.14 | +2.70% | +33.19% | +56.92% |
| JNJB34.SA | Johnson & Johnson | 93.72 BRL | +2.97% | +26.23% | +48.73% |
| 4AB.DE | AbbVie Inc. | 226.10 EUR | −2.54% | +17.94% | +29.69% |
| ABBV | AbbVie Inc. | $265.79 | +3.46% | +17.81% | +31.10% |
| ABBV34.SA | AbbVie Inc. | 85.03 BRL | +3.35% | +9.69% | +23.44% |
| MRCK34.SA | Merck & Co., Inc. | 100.37 BRL | +19.93% | +38.35% | +77.08% |
| 6MK.DE | Merck & Co., Inc. | 129.28 EUR | +11.62% | +44.70% | +83.96% |
| RHO.DE | Roche Holding AG | 400.20 EUR | −0.15% | +12.54% | +39.70% |
| MRK | Merck & Co., Inc. | $156.45 | +19.65% | +48.06% | +88.17% |
| NOT.DE | NOVARTIS AG N | 135.46 EUR | −3.15% | +18.61% | +27.82% |
| N1VS34.SA | Novartis AG | 82.08 BRL | +2.40% | +11.52% | +20.51% |
| NVS | Novartis AG | $159.98 | +2.48% | +18.99% | +31.84% |
| AZN.L | AstraZeneca PLC | 12,110.00 GBP | −6.41% | −10.89% | +1.98% |
| AZN.ST | AstraZeneca PLC | 1,568.00 SEK | −6.12% | −7.36% | +2.47% |
| AZN | AstraZeneca PLC | $169.66 | +0.01% | −6.39% | +7.60% |
| A1ZN34.SA | AstraZeneca PLC | 144.34 BRL | +0.85% | −12.75% | +1.51% |
| AMG.DE | Amgen Inc. | 378.10 EUR | +9.72% | +37.91% | +56.55% |
| AMGN34.SA | Amgen Inc. | 81.36 BRL | +17.28% | +69.77% | +47.86% |
| AMGN | Amgen Inc. | $442.24 | +17.54% | +36.94% | +56.64% |
| TMO | Thermo Fisher Scientific Inc. | $628.74 | +12.37% | +6.22% | +28.46% |
| TN8.DE | Thermo Fisher Scientific Inc. | 529.40 EUR | +4.71% | +5.35% | +27.50% |
| TMOS34.SA | Thermo Fisher Scientific Inc. | 67.27 BRL | +13.34% | −0.04% | +22.09% |
| NVO | Novo Nordisk A/S | $48.66 | −2.03% | −3.71% | −10.46% |
| NOV.DE | Novo Nordisk A/S | 40.03 EUR | −10.35% | +20.19% | +11.69% |
| NOVO-B.CO | Novo Nordisk A/S | 299.25 DKK | −10.78% | −6.26% | −13.21% |
| N1VO34.SA | Novo Nordisk A/S | 30.64 BRL | −2.73% | −12.21% | −17.65% |
| NVO.WA | NVONORDSK | 171.66 PLN | −9.40% | −3.40% | −11.47% |
| ABT | Abbott Laboratories | $116.13 | +11.14% | −5.43% | −10.54% |
| ABTT34.SA | Abbott Laboratories | 49.85 BRL | +12.07% | −10.73% | −15.33% |
| ABL.DE | Abbott Laboratories | 99.80 EUR | +5.14% | −4.18% | −9.70% |
| R1DY34.SA | Dr. Reddy's Laboratories Limited | 10.25 BRL | −15.29% | −14.30% | −21.76% |
| PODD | Insulet Corporation | $143.05 | −13.30% | −49.44% | −56.52% |
| NUVL | Nuvalent Inc | $123.96 | 0.00% | +22.93% | +67.40% |
| BIO-B | Bio-Rad Laboratories, Inc. | $365.08 | +18.01% | +17.50% | +47.78% |
| AVTR | Avantor, Inc. | $14.42 | +22.62% | +25.83% | +9.16% |
| OSCR | Oscar Health, Inc. | $30.93 | +9.14% | +106.61% | +85.10% |
| TWST | Twist Bioscience Corporation | $151.42 | +74.97% | +367.49% | +452.83% |
| WDH1.DE | Demant A/S | 39.10 EUR | +5.22% | +36.62% | −5.53% |
| DEMANT.CO | Demant A/S | 287.00 DKK | +0.99% | +34.49% | +17.33% |
| SYRE | Spyre Therapeutics, Inc. | $107.36 | +7.32% | +251.08% | +547.53% |
| KRK.WA | Krka, d. d. | 1,110.00 PLN | −2.46% | +29.07% | +31.52% |
| PCVX | Vaxcyte, Inc. | $61.09 | +10.07% | +31.49% | +100.62% |
| QGEN | Qiagen N.V. | $43.65 | +6.26% | −3.41% | −10.74% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $84.86 | +1.20% | +81.60% | +182.02% |
| IMVT | Immunovant, Inc. | $43.50 | +8.51% | +67.89% | +192.14% |
| QIA.DE | Qiagen N.V. | 36.41 EUR | −0.78% | −4.56% | −11.42% |
| HQY | HealthEquity, Inc. | $105.39 | +6.40% | +15.72% | +20.55% |
| 4523.T | Eisai Co., Ltd. | 4,911.00 JPY | +2.50% | +4.27% | +9.74% |
| BRKR | Bruker Corporation | $56.85 | −5.33% | +18.34% | +64.93% |
| ATR | AptarGroup, Inc. | $134.72 | +1.37% | +10.80% | −2.35% |
| 4151.T | Kyowa Kirin Co., Ltd. | 2,596.00 JPY | −2.26% | +3.26% | +3.09% |
| TGTX | TG Therapeutics, Inc. Common Stock | $56.01 | +0.47% | +91.29% | +96.32% |
| TXG | 10x Genomics, Inc. | $64.72 | +40.94% | +289.41% | +359.99% |
| ALKS | Alkermes plc | $49.21 | −6.68% | +74.13% | +69.69% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $113.35 | +6.80% | +7.94% | +14.26% |
| 6869.T | Sysmex Corporation | 1,957.00 JPY | +19.66% | +29.29% | +5.65% |
| HIMS | Hims & Hers Health, Inc. | $31.75 | +4.99% | −4.97% | −26.15% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | 2,511.00 JPY | +3.89% | +16.57% | +62.22% |
| 2413.T | M3, Inc. | 1,754.00 JPY | −8.67% | −14.21% | −20.12% |
| CAI | Caris Life Sciences, Inc. | $28.01 | +79.21% | +3.82% | −27.21% |
| RHC.AX | Ramsay Health Care Limited | 44.27 AUD | +2.00% | +29.22% | +18.74% |
| HNGE | Hinge Health, Inc. | $89.87 | +19.65% | +97.26% | +63.19% |
| ALK-B.CO | ALK-Abelló A/S | 214.20 DKK | −5.31% | −4.75% | +8.24% |
| SHL.AX | Sonic Healthcare Limited | 20.31 AUD | −7.72% | −7.74% | −11.60% |
| CHE | Chemed Corporation | $543.98 | +6.80% | +28.52% | +19.61% |
| SRRK | Scholar Rock Holding Corporation | $58.25 | +19.05% | +36.10% | +74.77% |
| GETI-B.ST | Getinge AB (publ) | 245.00 SEK | +4.17% | +15.36% | +21.56% |
| PACS | PACS Group, Inc. | $43.94 | −6.67% | +11.21% | +272.69% |
| CGON | CG Oncology, Inc. | $78.95 | +7.39% | +88.92% | +210.58% |
| 3391.T | Tsuruha Holdings Inc. | 2,422.50 JPY | −3.43% | −15.02% | +8.33% |
| 0126Z0.KS | SAMSUNG EPIS HOLDINGS | 380,000.00 KRW | +3.54% | −46.85% | +13.26% |
| ORKA | Oruka Therapeutics, Inc. | $101.82 | +12.88% | +260.17% | +601.72% |
| 7747.T | Asahi Intecc Co., Ltd. | 4,016.00 JPY | +12.49% | +35.31% | +58.61% |
| RADL3.SA | Raia Drogasil S.A. | 19.59 BRL | +7.82% | −16.98% | +12.04% |
| E2XE34.SA | Exelixis, Inc. | 137.40 BRL | −2.25% | +23.92% | +23.92% |
| HLUN-B.CO | H. Lundbeck A/S | 41.54 DKK | −1.33% | −0.38% | +5.61% |
| LNTH | Lantheus Holdings, Inc. | $100.87 | −6.63% | +49.95% | +79.61% |
| HLUN-A.CO | H. Lundbeck A/S | 41.00 DKK | +12.95% | +14.64% | +26.06% |
| BLTE | Belite Bio, Inc | $161.68 | +2.05% | +1.51% | +154.13% |
| 3088.T | MatsukiyoCocokara & Co. | 2,606.50 JPY | +0.66% | −2.95% | −14.17% |
| COGT | Cogent Biosciences, Inc. | $36.80 | −9.00% | +5.93% | +212.13% |
| COH.AX | Cochlear Limited | 138.52 AUD | +15.55% | −46.26% | −53.16% |
| LQDA | Liquidia Corporation | $70.49 | −16.50% | +124.49% | +168.53% |
| CNTA | Centessa Pharmaceuticals plc | $40.50 | 0.00% | +70.96% | +138.24% |
| AMRX | Amneal Pharmaceuticals, Inc. | $17.92 | −0.94% | +41.55% | +93.10% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $80.20 | +26.23% | +90.93% | +142.74% |
| BLCO | Bausch + Lomb Corporation | $17.25 | +5.96% | +4.04% | +18.72% |
| ERAS | Erasca, Inc. | $17.76 | −5.88% | +394.71% | +1016.98% |
| BLCO.TO | Bausch + Lomb Corporation | 23.84 CAD | +3.79% | +4.61% | +18.08% |
| PTCT | PTC Therapeutics, Inc. Common Stock | $73.47 | −3.07% | −4.26% | +49.03% |
| DNTH | Dianthus Therapeutics, Inc. | $112.11 | +7.29% | +182.54% | +378.90% |
| STVN | Stevanato Group S.p.A. | $22.70 | +14.65% | +10.30% | +3.23% |
| TVTX | Travere Therapeutics, Inc. | $67.01 | +18.23% | +69.56% | +288.91% |
| CTEC.L | Convatec Group PLC | 228.00 GBP | −0.09% | −4.83% | −2.30% |
| RDNT | RadNet, Inc. | $76.86 | +24.96% | +8.33% | +10.45% |
| DFTX | Definium Therapeutics, Inc. | $44.81 | +5.06% | +228.52% | +354.92% |
| T1FX34.SA | Teleflex Incorporated | 69.78 BRL | 0.00% | +3.04% | +0.29% |
| MIRM | Mirum Pharmaceuticals, Inc. | $98.08 | −14.12% | +25.63% | +36.58% |
| TFX | Teleflex Incorporated | $140.18 | +6.97% | +15.16% | +10.85% |
| CRSP | CRISPR Therapeutics AG | $60.90 | +30.32% | +13.26% | +12.51% |
| XENE | Xenon Pharmaceuticals Inc. | $60.42 | −8.15% | +35.81% | +58.42% |
| SECT-B.ST | Sectra AB (publ) | 275.80 SEK | −1.15% | +15.11% | −19.07% |
| LGND | Ligand Pharmaceuticals Incorporated | $281.72 | −5.30% | +48.19% | +77.42% |
| MMED | MiniMed Group, Inc. | $18.92 | +7.07% | +2.33% | +2.33% |
| SHC | Sotera Health Company | $19.51 | +13.17% | +10.29% | +19.04% |
| MMSI | Merit Medical Systems, Inc. | $91.09 | +19.70% | +5.37% | +3.32% |
| GRFS | Grifols, S.A. | $8.09 | +4.39% | −12.45% | −17.62% |
| ACAD | ACADIA Pharmaceuticals Inc. | $30.57 | +20.40% | +16.28% | +20.73% |
| HAE | Haemonetics Corporation | $108.32 | +35.55% | +35.43% | +96.13% |
| DYN | Dyne Therapeutics, Inc. | $26.34 | +2.77% | +42.38% | +102.62% |
| 326030.KS | SK Biopharmaceuticals Co., Ltd. | 86,200.00 KRW | +8.43% | −29.86% | −14.48% |
| EWTX | Edgewise Therapeutics, Inc. | $44.21 | +6.27% | +86.15% | +209.16% |
| BLLN | BillionToOne, Inc. | $100.08 | −21.80% | +12.08% | −8.14% |
| LFST | LifeStance Health Group, Inc. | $12.28 | +12.87% | +76.44% | +127.83% |
| 000100.KS | Yuhan Corporation | 86,000.00 KRW | +21.64% | −23.35% | −25.59% |
| WAY | Waystar Holding Corp. | $24.21 | +4.69% | −22.82% | −32.56% |
| HIK.L | Hikma Pharmaceuticals PLC | 1,633.00 GBP | +1.24% | +7.25% | −11.37% |
| ICUI | ICU Medical, Inc. | $182.24 | +12.87% | +31.55% | +44.85% |
| OBCK.DE | Ottobock SE & Co. KGaA I | 59.50 EUR | +4.94% | −0.82% | −0.82% |
| DOCS | Doximity, Inc. | $24.74 | +17.87% | −42.85% | −62.74% |
| RLAY | Relay Therapeutics, Inc. | $20.57 | +10.35% | +151.47% | +486.04% |
| ELVN | Enliven Therapeutics, Inc. | $61.01 | +15.69% | +292.60% | +205.89% |
| 128940.KS | Hanmi Pharm. Co., Ltd. | 539,500.00 KRW | +44.06% | +22.23% | +80.49% |
| CELC | Celcuity Inc. | $92.27 | +12.16% | −8.23% | +87.35% |
| CON | Concentra Group Holdings Parent, Inc. | $34.78 | +9.06% | +80.13% | +49.74% |
| NVST | Envista Holdings Corporation | $27.47 | +3.12% | +26.65% | +30.07% |
| LIVN | LivaNova PLC | $79.41 | −1.45% | +30.95% | +40.92% |
| HTFL | Heartflow, Inc. | $49.89 | +96.65% | +72.21% | +67.19% |
| ITGR | Integer Holdings Corporation | $125.39 | +26.15% | +63.31% | +15.26% |
| INDV | Indivior Pharmaceuticals, Inc. | $35.97 | −10.14% | +0.67% | +49.81% |
| ADPT | Adaptive Biotechnologies Corporation | $26.25 | +16.46% | +64.99% | +107.18% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $37.46 | +92.20% | +228.02% | +340.71% |
| ANN.AX | Ansell Limited | 41.16 AUD | +25.93% | +18.26% | +22.31% |
| 4506.T | Sumitomo Pharma Co., Ltd. | 1,476.50 JPY | +14.24% | −40.00% | −2.73% |
| LEGN | Legend Biotech Corporation | $21.30 | +10.53% | −0.98% | −38.44% |
| TNGX | Tango Therapeutics, Inc. | $24.51 | −8.27% | +174.47% | +264.73% |
| MANE | Veradermics, Incorporated | $102.35 | −8.14% | +171.13% | +171.13% |
| IDYA | IDEAYA Biosciences, Inc. | $42.48 | +15.53% | +25.49% | +71.91% |
| IRTC | iRhythm Holdings, Inc. | $123.09 | +9.75% | −29.75% | −25.71% |
| ABCL | AbCellera Biologics Inc. | $12.50 | +138.10% | +264.43% | +195.51% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | 22.90 EUR | +6.02% | +57.53% | −0.90% |
| RCUS | Arcus Biosciences, Inc. | $31.57 | +13.40% | +35.55% | +211.03% |
| VKTX | Viking Therapeutics, Inc. | $34.17 | −2.01% | −3.53% | +32.19% |
| DNLI | Denali Therapeutics Inc. | $24.93 | +5.77% | +53.23% | +60.12% |
| TLX | Telix Pharmaceuticals Limited | $11.68 | +17.03% | +53.28% | −4.26% |
| MCOV-B.ST | Medicover AB (publ) | 242.00 SEK | +5.91% | +14.26% | −10.12% |
| TLX.AX | Telix Pharmaceuticals Limited | 16.06 AUD | +10.99% | +41.37% | −12.72% |
| BBZA.DE | BB Biotech AG | 33.40 EUR | 0.00% | +7.22% | +7.22% |
| 000105.KS | Yuhan Corporation | 71,600.00 KRW | +17.76% | −29.29% | −31.05% |
| CAMX.ST | Camurus AB (publ) | 609.50 SEK | −2.25% | −0.41% | −14.52% |
| CPRX | Catalyst Pharmaceuticals Inc | $31.49 | 0.00% | +36.03% | +52.72% |
| FIE.DE | Fielmann Group AG | 39.40 EUR | −5.06% | −9.74% | −30.39% |
| IOVA | Iovance Biotherapeutics, Inc. | $8.44 | +72.24% | +234.92% | +233.60% |
| 4536.T | Santen Pharmaceutical Co., Ltd. | 1,882.50 JPY | −3.95% | +15.60% | +22.85% |
| 7459.T | MediPal Holdings Corporation | 2,933.00 JPY | −1.26% | +6.35% | +14.74% |
| GRAL | GRAIL, Inc. | $82.54 | +23.62% | −7.12% | +150.69% |
| OGN | Organon & Co. | $13.75 | +1.55% | +90.67% | +52.78% |
| A2LC34.SA | Alcon Inc. | 38.00 BRL | +11.50% | −13.23% | −12.91% |
| GPCR | Structure Therapeutics Inc. | $49.92 | +2.53% | −26.72% | +168.82% |
| QURE | uniQure N.V. | $51.05 | +33.60% | +118.26% | +228.30% |
| OPCH | Option Care Health, Inc. | $23.64 | +8.39% | −26.67% | −15.75% |
| VCYT | Veracyte, Inc. Common Stock | $44.04 | −20.81% | +3.89% | +49.04% |
| NHC | National HealthCare Corporation | $224.73 | −0.60% | +73.01% | +103.48% |
| PLSE | Pulse Biosciences, Inc. | $49.13 | +49.83% | +266.92% | +197.94% |
| ZEAL.CO | Zealand Pharma A/S | 309.40 DKK | +1.14% | −32.75% | −27.05% |
| IMNM | Immunome, Inc. | $29.39 | +30.14% | +41.14% | +196.22% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $9.00 | +34.53% | +164.71% | +275.00% |
| MBX | MBX Biosciences, Inc. | $68.62 | +11.94% | +124.62% | +394.02% |
| 3349.T | COSMOS Pharmaceutical Corporation | 6,573.00 JPY | −0.59% | −14.46% | −27.10% |
| NAMS | NewAmsterdam Pharma Company N.V. | $27.34 | −9.53% | −22.33% | +10.69% |
| AFX.DE | Carl Zeiss Meditec AG | 32.30 EUR | +12.39% | −16.64% | −23.23% |
| WRBY | Warby Parker Inc. | $26.00 | +4.59% | +14.94% | −0.61% |
| BIOA-B.ST | BioArctic AB (publ) | 329.80 SEK | +2.23% | +6.74% | +20.03% |
| CLDX | Celldex Therapeutics, Inc. | $41.22 | +15.62% | +52.61% | +87.96% |
| TMDX | TransMedics Group, Inc. | $93.60 | +26.01% | −23.71% | −18.59% |
| VIRP.PA | Virbac SA | 329.00 EUR | −4.78% | −6.93% | −2.81% |
| BEAM | Beam Therapeutics Inc. | $31.03 | +23.77% | +14.33% | +88.75% |
| AMBU-B.CO | Ambu A/S | 78.25 DKK | +7.78% | −9.28% | −19.61% |
| TARS | Tarsus Pharmaceuticals, Inc. | $71.45 | +18.85% | −11.54% | +26.21% |
| 7649.T | Sugi Holdings Co.,Ltd. | 2,729.00 JPY | −6.22% | −25.12% | −28.33% |
| IRON | Disc Medicine, Inc. | $82.41 | +10.45% | +4.20% | +38.71% |
| ARQT | Arcutis Biotherapeutics, Inc. | $24.86 | −10.70% | −14.28% | +58.44% |
| ASKER.ST | Asker Healthcare Group AB (publ) | 76.10 SEK | −2.93% | −7.03% | −22.60% |
| HYPE3.SA | Hypera S.A. | 21.80 BRL | +3.51% | −5.49% | −4.08% |
| ALMS | Alumis Inc. | $23.96 | −11.52% | +167.56% | +388.98% |
| AVAH | Aveanna Healthcare Holdings Inc. | $13.59 | +40.54% | +68.19% | +82.91% |
| ZLAB | Zai Lab Limited | $26.17 | +40.40% | +51.01% | −23.10% |
| BKD | Brookdale Senior Living Inc. | $12.20 | −21.14% | +12.55% | +59.90% |
| SLS | SELLAS Life Sciences Group, Inc. | $14.09 | +29.98% | +223.91% | +637.70% |
| ALHC | Alignment Healthcare, Inc. | $13.59 | −27.21% | −32.79% | −12.77% |
| ACHC | Acadia Healthcare Company, Inc. | $29.87 | −8.09% | +109.03% | +34.73% |
| 9989.T | Sundrug Co.,Ltd. | 3,741.00 JPY | −3.90% | −11.25% | −17.00% |
| RGC | Regencell Bioscience Holdings Limited | $5.54 | −4.97% | −73.03% | −54.89% |
| VRDN | Viridian Therapeutics, Inc. | $24.18 | +22.74% | −21.19% | +30.21% |
| ATAI | AtaiBeckley Inc. | $7.44 | +3.77% | +92.25% | +56.96% |
| NRIX | Nurix Therapeutics, Inc. | $26.95 | +15.02% | +49.22% | +178.70% |
| EBO.AX | EBOS Group Limited | 18.77 AUD | +4.45% | −18.40% | −35.38% |
| PRVA | Privia Health Group, Inc. | $21.20 | −14.07% | −9.63% | −0.93% |
| AXGN | AxoGen, Inc. Common Stock | $49.93 | +21.37% | +61.06% | +237.59% |
| CDNA | CareDx, Inc. | $50.80 | +39.71% | +165.41% | +298.43% |
| SUPN | Supernus Pharmaceuticals, Inc. | $45.36 | −3.45% | −8.31% | +2.09% |
| PHVS | Pharvaris N.V. | $37.31 | +9.83% | +40.90% | +57.76% |
| RARE | Ultragenyx Pharmaceutical Inc. | $26.46 | −1.60% | +12.12% | −9.60% |
| WGS | GeneDx Holdings Corp. | $87.41 | +44.38% | −33.93% | −28.28% |
| B72.DE | AtaiBeckley Inc. | 6.45 EUR | +2.38% | +88.27% | +57.16% |
| CURA.TO | Curaleaf Holdings, Inc. | 13.57 CAD | +7.44% | +279.05% | +225.42% |
| EMEIS.PA | EMEIS | 14.07 EUR | +3.46% | −3.76% | +10.18% |
| PGEN | Precigen, Inc. | $7.28 | +34.32% | +70.09% | +82.91% |
| BV3.DE | BAVARIAN NORDIC N | 28.96 EUR | +20.97% | +12.03% | +14.47% |
| BAVA.CO | Bavarian Nordic A/S | 213.00 DKK | +19.39% | +10.48% | −10.13% |
| 2784.T | Alfresa Holdings Corporation | 2,327.00 JPY | −3.60% | −4.09% | +7.97% |
| TRVI | Trevi Therapeutics, Inc. | $17.95 | −0.94% | +50.97% | +146.57% |
| VERA | Vera Therapeutics, Inc. | $35.28 | +0.28% | −27.44% | +65.32% |
| NEOG | Neogen Corporation | $11.64 | +24.63% | +66.29% | +107.86% |
| BHC.TO | Bausch Health Companies Inc. | 9.31 CAD | +46.85% | −6.15% | −8.00% |
| NKTR | Nektar Therapeutics | $74.96 | +5.06% | +72.64% | +176.20% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $9.83 | +2.61% | +31.07% | +17.16% |
| BHC | Bausch Health Companies Inc. | $6.73 | +50.22% | −6.66% | −7.81% |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | 4,184.00 JPY | +5.79% | −6.48% | +6.99% |
| NUVB | Nuvation Bio Inc. | $7.10 | +6.61% | −17.25% | +146.53% |
| KOD | Kodiak Sciences Inc. | $39.46 | −5.85% | +51.65% | +316.68% |
| ATRC | AtriCure, Inc. | $48.68 | +30.26% | +23.96% | +28.65% |
| PBH | Prestige Consumer Healthcare Inc. | $51.45 | +2.08% | −15.96% | −21.64% |
| RAPP | Rapport Therapeutics, Inc. | $51.17 | +21.47% | +82.03% | +249.76% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | 110.60 EUR | +15.57% | +65.89% | +63.50% |
| ONT.L | Oxford Nanopore Technologies plc | 166.70 GBP | +49.78% | +30.23% | −14.60% |
| DMP.DE | Dermapharm Holding SE | 39.80 EUR | −4.67% | +3.24% | +14.86% |
| BFLY | Butterfly Network, Inc. | $9.04 | +27.86% | +141.07% | +483.23% |
| OCUL | Ocular Therapeutix, Inc. | $10.88 | +25.93% | −7.95% | −8.34% |
| GRDN | Guardian Pharmacy Services, Inc. | $37.30 | −10.03% | +26.31% | +42.20% |
| UFPT | UFP Technologies, Inc. | $304.21 | +22.35% | +36.17% | +37.69% |
| MLYS | Mineralys Therapeutics, Inc. | $26.34 | −3.20% | −26.24% | +78.70% |
| 009420.KS | Hanall Biopharma Co., Ltd. | 63,300.00 KRW | +40.04% | +50.00% | +108.57% |
| COAG | Hemab Therapeutics Holdings, Inc. | $49.65 | −1.47% | +46.03% | +46.03% |
| ALMR | Alamar Biosciences, Inc. | $33.02 | +35.33% | +50.09% | +50.09% |
| GENB | Generate Biomedicines, Inc. | $20.38 | +48.98% | +61.11% | +61.11% |
| HRMY | Harmony Biosciences Holdings, Inc. | $38.95 | +8.16% | +4.20% | +4.09% |
| URGN | UroGen Pharma Ltd. | $46.36 | +11.82% | +104.14% | +150.59% |
| EKTA-B.ST | Elekta AB (publ) | 55.60 SEK | +13.75% | +0.06% | +19.21% |
| ADUS | Addus HomeCare Corporation | $121.09 | +4.70% | +13.61% | +3.81% |
| 008930.KS | Hanmi Science Co., Ltd. | 45,400.00 KRW | +33.73% | +25.36% | +10.13% |
| MSB.AX | Mesoblast Limited | 2.40 AUD | +16.26% | −13.54% | −3.82% |
| MESO | Mesoblast Limited | $17.19 | +18.06% | −5.34% | +9.42% |
| AUPH | Aurinia Pharmaceuticals Inc. | $16.75 | +10.05% | +9.12% | +38.03% |
| VCEL | Vericel Corporation | $43.22 | −4.63% | +21.37% | +20.76% |
| ZBIO | Zenas BioPharma, Inc. | $33.77 | +2.89% | −2.12% | +103.93% |
| CLOV | Clover Health Investments, Corp. | $4.13 | −3.28% | +71.37% | +56.14% |
| MD | Pediatrix Medical Group, Inc. | $26.99 | +3.25% | +26.77% | +58.21% |
| XRAY | DENTSPLY SIRONA Inc. | $10.97 | −15.75% | −2.66% | −21.70% |
| NEO | NeoGenomics, Inc. | $16.79 | +27.78% | +42.77% | +160.31% |
| XNCR | Xencor, Inc. Common Stock | $29.30 | +47.53% | +96.38% | +265.79% |
| EXE.TO | Extendicare Inc. | 31.70 CAD | −17.30% | +51.39% | +147.28% |
| BHVN | Biohaven Ltd. | $14.38 | −0.90% | +32.66% | −3.75% |
| 9987.T | Suzuken Co., Ltd. | 5,109.00 JPY | −3.28% | −17.12% | −11.16% |
| STOK | Stoke Therapeutics, Inc. | $33.46 | +14.16% | +8.28% | +77.32% |
| CLOV34.SA | Clover Health Investments, Corp. | 20.84 BRL | −8.68% | +57.16% | +44.32% |
| ESTA | Establishment Labs Holdings Inc. | $72.15 | −21.66% | +4.81% | +77.45% |
| GN.CO | GN Store Nord A/S | 93.12 DKK | −0.64% | −15.27% | −19.72% |
| KLRA | Kailera Therapeutics, Inc. | $17.75 | +1.54% | −31.73% | −31.73% |
| ADMA | ADMA Biologics, Inc. | $9.72 | +14.62% | −45.64% | −42.86% |
| PVLA | Palvella Therapeutics, Inc. | $148.24 | +4.56% | +47.83% | +195.71% |
| 302440.KS | SK bioscience Co.,Ltd. | 37,600.00 KRW | +11.24% | −21.67% | −22.23% |
| HCM | HUTCHMED (China) Limited | $12.26 | +10.25% | −10.18% | −23.04% |
| HCM.L | HUTCHMED (China) Limited | 178.00 GBP | +0.85% | −12.75% | −21.24% |
| NANO.PA | Nanobiotix S.A. | 34.14 EUR | +3.96% | +79.68% | +341.09% |
| NBTX | Nanobiotix S.A. | $41.51 | +3.31% | +87.57% | +321.42% |
| ALIF-B.ST | AddLife AB (publ) | 162.40 SEK | +0.74% | +8.24% | −7.56% |
| GNS.L | Genus plc | 2,288.00 GBP | +3.16% | −10.09% | −13.32% |
| NEU.AX | Neuren Pharmaceuticals Limited | 22.51 AUD | +32.02% | +19.04% | +18.47% |
| PIII | P3 Health Partners Inc. | $10.03 | −4.29% | +186.57% | +35.72% |
| CMPS | COMPASS Pathways plc | $14.88 | +32.03% | +127.18% | +224.89% |
| NVCR | NovoCure Limited | $17.62 | +3.46% | +34.30% | +50.60% |
| SEM | Select Medical Holdings Corp | $16.51 | −0.12% | +12.30% | +26.87% |
| 6960.T | Fukuda Denshi Co., Ltd. | 11,900.00 JPY | +2.23% | +56.36% | +78.59% |
| TSHA | Taysha Gene Therapies, Inc. | $6.20 | +11.91% | +18.10% | +112.33% |
| PRGO | Perrigo Company plc | $14.48 | +42.80% | +6.59% | −36.97% |
| EMBLA.CO | Embla Medical hf | 30.25 DKK | +6.89% | −5.47% | −5.76% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.